Related Experiment Video
Updated: Jun 6, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
The value of epigenetic markers in esophageal cancer
Xiao-Mei Zhang1, Ming-Zhou Guo
1Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, Beijing, 100853, China.
Abstract:
Developing esophageal cancer is a multi-step process that begins with the accumulation of genetic and epigenetic alterations, and leads to the activation of oncogenes and the inactivation or loss of tumor suppressor genes (TSG). In addition to genetic alteration, epigenetic modifications, and in particular DNA methylation, are recognized as a common molecular alteration in human tumors. In esophageal cancer, aberrant methylation of promoter regions occurs not only in advanced cancer, but also in premalignant lesions. DNA methylation is related to survival time and sensitivity of chemoradiotherapy. This review is mainly focused on epigenetic changes in esophageal cancer and the value of early detection for patient prognosis, treatment choices, and potential targeting therapy.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
